<- Go Home
Auriga Laboratories, Inc.
Auriga Laboratories, Inc., a specialty pharmaceutical company, engages in the licensing, development, and commercialization of prescription pharmaceutical products. It offers products in respiratory and dermatology therapeutic categories for primary care physicians, pediatricians, dermatologists, urologists, psychiatrists, and rheumatologists. The company was founded in 2005 and is headquartered in Norcross, Georgia.
Market Cap
$39.8K
Volume
301.1K
Cash and Equivalents
$57.5K
EBITDA
-$13.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$2.4M
Profit Margin
36.73%
52 Week High
$0.01
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
-0.00
Price / Earnings
-0.00
Price / Tangible Book Value
-0.00
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$13.6M
Return on Equity
1375.20%
Return on Assets
-90.58
Cash and Short Term Investments
$57.5K
Debt
$705.3K
Equity
-$7.9M
Revenue
$6.5M
Unlevered FCF
$1.2M
Sector
Pharmaceuticals
Category
N/A